WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for STOK

Based on 8 analysts offering 12 month price targets for Stoke Therapeutics Inc

Min Forecast
$35.00+11.46%
Avg Forecast
$44.50+41.72%
Max Forecast
$60.00+91.08%

Should I buy or sell STOK stock?

Based on 8 analysts offering ratings for Stoke Therapeutics Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although STOK's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates STOK as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their STOK stock forecasts and price targets.

STOK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-08-04
lockedlocked$00.00+00.00%2026-07-13
BTIG
Top 30%
71
Strong BuyReiterates$39.00+24.20%2026-05-11
Needham
Top 2%
99
BuyMaintains$40.00+27.39%2026-03-17
Wolfe Research
Top 2%
99
BuyInitiates Coverage On$40.00+27.39%2026-02-24

1 of 1

Forecast return on equity

Is STOK forecast to generate an efficient return?

Company
-6.86%
Industry
15.45%
Market
168.37%
STOK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is STOK forecast to generate an efficient return on assets?

Company
-6.01%
Industry
23.26%
STOK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STOK earnings per share forecast

What is STOK's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
-$3.40
Avg 2 year Forecast
-$3.23
Avg 3 year Forecast
-$1.78

STOK revenue forecast

What is STOK's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$32.3M+16.97%
Avg 2 year Forecast
$51.5M+86.73%
Avg 3 year Forecast
$137.6M+398.62%
STOK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STOK revenue growth forecast

How is STOK forecast to perform vs Biotechnology companies and vs the US market?

Company
65.06%
Industry
32.77%
Market
13.34%
STOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STOK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STOK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
STOK$31.40$44.50+41.72%Strong Buy
SRPT$19.22$24.43+27.10%Hold
BHVN$13.50$18.33+35.80%Buy
AGIO$33.63$41.25+22.66%Buy
XNCR$27.00$27.000.00%Strong Buy
View Top Biotech Stocks

Stoke Therapeutics Stock Forecast FAQ

Is Stoke Therapeutics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: STOK) stock is to Strong Buy STOK stock.

Out of 8 analysts, 5 (62.5%) are recommending STOK as a Strong Buy, 3 (37.5%) are recommending STOK as a Buy, 0 (0%) are recommending STOK as a Hold, 0 (0%) are recommending STOK as a Sell, and 0 (0%) are recommending STOK as a Strong Sell.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.

What is STOK's earnings growth forecast for 2026-2028?

(NASDAQ: STOK) Stoke Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.53%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.27%.

Stoke Therapeutics's earnings in 2026 is -$207,902,000.On average, 16 Wall Street analysts forecast STOK's earnings for 2026 to be -$219,163,381, with the lowest STOK earnings forecast at -$239,663,368, and the highest STOK earnings forecast at -$208,000,341. On average, 16 Wall Street analysts forecast STOK's earnings for 2027 to be -$208,232,636, with the lowest STOK earnings forecast at -$232,075,082, and the highest STOK earnings forecast at -$138,892,736.

In 2028, STOK is forecast to generate -$114,888,974 in earnings, with the lowest earnings forecast at -$205,516,081 and the highest earnings forecast at -$45,394,211.

What is STOK's revenue growth forecast for 2026-2028?

(NASDAQ: STOK) Stoke Therapeutics's forecast annual revenue growth rate of 65.06% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 32.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.34%.

Stoke Therapeutics's revenue in 2026 is $27,588,000.On average, 16 Wall Street analysts forecast STOK's revenue for 2026 to be $2,082,197,303, with the lowest STOK revenue forecast at $1,011,771,475, and the highest STOK revenue forecast at $3,977,074,926. On average, 15 Wall Street analysts forecast STOK's revenue for 2027 to be $3,324,004,830, with the lowest STOK revenue forecast at $1,264,714,343, and the highest STOK revenue forecast at $7,114,018,181.

In 2028, STOK is forecast to generate $8,876,229,850 in revenue, with the lowest revenue forecast at $5,172,681,664 and the highest revenue forecast at $14,573,251,756.

What is STOK's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: STOK) forecast ROA is -6.01%, which is lower than the forecast US Biotechnology industry average of 23.26%.

What is STOK's Price Target?

According to 8 Wall Street analysts that have issued a 1 year STOK price target, the average STOK price target is $44.50, with the highest STOK stock price forecast at $60.00 and the lowest STOK stock price forecast at $35.00.

On average, Wall Street analysts predict that Stoke Therapeutics's share price could reach $44.50 by Aug 4, 2027. The average Stoke Therapeutics stock price prediction forecasts a potential upside of 41.72% from the current STOK share price of $31.40.

What is STOK's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: STOK) Stoke Therapeutics's current Earnings Per Share (EPS) is -$3.37. On average, analysts forecast that STOK's EPS will be -$3.40 for 2026, with the lowest EPS forecast at -$3.71, and the highest EPS forecast at -$3.22. On average, analysts forecast that STOK's EPS will be -$3.23 for 2027, with the lowest EPS forecast at -$3.60, and the highest EPS forecast at -$2.15. In 2028, STOK's EPS is forecast to hit -$1.78 (min: -$3.19, max: -$0.70).

What is STOK's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: STOK) forecast ROE is -6.86%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.